KAIST

NEWS

홈페이지 통합검색

-
KOREAN

Hyung-Soon+Park

KAIST Showcases Healthcare Technologies at K-Hospital Fair 2020 KAIST Pavilion showcased its innovative medical and healthcare technologies and their advanced applications at the K-Hospital Fair 2020. Five KAIST research groups who teamed up for the Post-COVID-19 New Deal R&D Initiative Project participated in the fair held in Seoul last week. The K-Hospital Fair is a yearly event organized by the Korean Hospital Association to present the latest research and practical innovations to help the medical industry better serve the patients. This year, 120 healthcare organizations participated in the fair and operated 320 booths. At the fair, a research group led by Professor Il-Doo Kim from the Department of Materials Science and Engineering demonstrated the manufacturing process of orthogonal nanofibers used to develop their ‘recyclable nano-fiber filtered face mask’ introduced in March of this year. This mask has garnered immense international attention for maintaining its sturdy frame and filtering function even after being washed more than 20 times. Professor Kim is now extending his facilities for the mass production of this mask at his start-up company. While awaiting final approval from the Ministry of Food and Drug Safety to bring his product into the market, Professor Kim is developing other mask variations such as eco-friendly biodegradable masks and transparent masks to aid the hearing-impaired who rely on lip reading to communicate. The team working under Professor Wonho Choe from the Department of Nuclear and Quantum Engineering presented two low-temperature plasma sterilizers for medical use, co-developed with Plasmapp, a start-up company founded by a KAIST alumnus. Their sterilizers are the first ones that can sterilize medical devices by diffusing hydrogen peroxide vapor into the pouch. They rapidly sterilize medical instruments and materials in just seven minutes without leaving toxic residue, while reducing sterilization time and costs by 90%. Professor Hyung-Soon Park and his researchers from the Department of Mechanical Engineering introduced a smart protective suit ventilation system that features high cooling capacity and a slimmed-down design. For comfortable use, the suit is equipped with a technique that monitors its inner temperature and humidity and automatically controls its inner circulation accordingly. The group also presented a new system that helps a person in a contaminated suit undress without coming into contact with the contaminated outer part of the suit. Professor Jong Chul Ye's group from the Department of Bio and Brain Engineering demonstrated AI software that can quickly diagnose an infectious disease based on chest X-ray imaging. The technique compares the differences in the severity of pneumonia in individual patients to distinguish whether their conditions fall under viral pneumonia including COVID-19, bacterial pneumonia, tuberculosis, other diseases, or normal conditions. The AI software visualizes the basis of its reasoning for each of the suspected diseases and provides them as information that can be utilized by medical personnel. Finally, researchers of Professor Ki-Hun Jeong’s team from the Department of Bio and Brain Engineering demonstrated their ultra-high-speed sub-miniature molecular diagnostic system for the on-site diagnosis of diseases. The existing Polymerase Chain Reaction (PCR) diagnostic usually takes from 30 minutes to an hour to provide results, but their new technique using an LED light source can present results within just three minutes and it is expected to be used actively for on-site diagnosis. Professor Choongsik Bae, the Director of the Post-COVID-19 New Deal R&D Initiative Project, said, “KAIST will build a healthy relationship amongst researchers, enterprises, and hospitals to contribute to the end of COVID-19 and build a new paradigm of Korean disease prevention and control.” KAIST launched the Post-COVID-19 New Deal R&D Initiative in July with the support of the Ministry of Science and ICT of Korea. This unit was created to overcome the pandemic crisis by using science and technology, and to contribute to economic development by creating a new antiviral drug industry. The unit is comprised of 464 KAIST members including professors, researchers, and students as well as 503 professionals from enterprises, hospitals, and research centers. (END)
2020.10.26 View 11846

KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea T.042-350-2114 F.042-350-2210(2220)